Skip to content

5-MeO-DMT: all studies

Page 103 of 110: studies 1,021 to 1,030 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography.

Biochemical Pharmacology May 1, 1987 B R Sitaram, R Talomsin, G L Blackman et al. 23 citations

The use of a series of liquid chromatographic techniques involving cation-exchange, reverse-phase and normal-phase chromatography has permitted the separation and characterisation of a number of metabolites of the psychotomimetic indolealkylamines N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine which were isolated following incubation of these compounds with rat tissue extracts. In...

Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine.

European Journal of Pharmacology March 3, 1987 Toshitaka Nabeshima, H Fukaya, K Yamaguchi et al. 70 citations

In rats treated with phencyclidine (PCP) repeatedly (PCP 10 mg/kg per day for 14 days), the back-pedalling, head-weaving and turning induced by PCP were attenuated (tolerance), while PCP-induced sniffing, rearing and ambulation were potentiated (supersensitivity). The behavior induced by the direct and indirect serotonin (5-HT) agonists, 5-methoxy-N,N-dimethyltryptamine and p-chloroamphetamine,...

Phencyclidine-induced head-twitch response in rats treated chronically with methysergide.

European Journal of Pharmacology January 20, 1987 Toshitaka Nabeshima, K Ishikawa, K Yamaguchi et al. 27 citations

This study was designed to assess whether phencyclidine (PCP)-induced behaviors in rats were potentiated after two days' withdrawal from chronic methysergide (a 5-HT2 receptor blocker) treatment (10 mg/kg per day i.p. for 12 days), in order to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions. The PCP (10 mg/kg)-induced behaviors (head-twitch, head-weaving, turning...

In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine

European Journal of Nuclear Medicine and Molecular Imaging July 1, 1986 Kazuhiko Yanai, Tatsuo Ido, Kiichi Ishiwata et al. 2 citations

The endogenous hallucinogen, N,N-dimethyltryptamine (DMT), was labeled with carbon-11 and its regional distribution in rat brain studied. [11C]DMT showed higher accumulation in the cerebral cortex, caudate putamen, and amygdaloid nuclei. Studies of the subcellular distribution of [11C]DMT revealed the specific localization in the fractions enriched with serotonin receptors only when a very low...

DOI: 10.1007/bf00276707 (opens in new tab) Serotonin Radioligand Hallucinogen Pargyline +7

Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.

Pharmacology, Biochemistry, and Behavior June 1, 1986 L M Smith, S J Peroutka 245 citations

The effects of 8-hydroxy-2-(di-n-propyl-amino) tetralin (8-OH-DPAT), 5-methoxy-N,N-dimethyltryptamine (5-MeODMT), buspirone and isapirone were examined at 5-hydroxytryptamine1A (5-HT1A) binding sites and on the 5-HT behavioral syndrome in the rat. 8-OH-DPAT, 5-MeODMT, buspirone and isapirone are all potent inhibitors of 3H-8-OH-DPAT binding to rat brain membranes (Ki values = 1.9-13 nM)....

A primate model for the study of hallucinogens.

Pharmacology, Biochemistry, and Behavior February 1986 R F Schlemmer, J M Davis

An animal model for studying the actions of hallucinogenic drugs using primate social colonies is presented. Although hallucinogens induce a number of behavioral changes in this paradigm, one emergent behavior, limb jerks, appears to be selectively induced by three classes of hallucinogens in doses which correlate with those reported to be hallucinogenic in humans. Several non-hallucinogenic...

Opioid-hallucinogen interactions.

Pharmacology, Biochemistry, and Behavior February 1986 E F Domino

Before the advent of neuroleptics, opioids such as morphine were used occasionally in the treatment of schizophrenia and other mental disorders. Recent interest in the possible therapeutic role of endogenous opioid peptides in various mental states has prompted a new look at the opioids. The present paper summarizes the research to date in the author's laboratory on opioid-hallucinogen...

Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat.

Pharmacology, Biochemistry, and Behavior February 1, 1986 A A Larson, E G Anderson

The dorsal root potential (DRP) evoked by stimulation of the inferior central nucleus (ICN) of the cat is affected by administration of a variety of hallucinogenic agents. It has been previously shown that a single low dose of LSD is unique in that it potentiates this DRP, while injections of 5-methoxy-N,N- dimethyltryptamine (5-MeODMT), ketamine or phencyclidine (PCP) inhibit its production....

Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.

Journal of Neurochemistry 1986 J J Grome, A M Harper 40 citations

Substances with varying structural components have been shown to have 5-hydroxytryptamine (5-HT)-like properties in the CNS. In this study, putative 5-HT agonists with indoleamine moeities--lysergic acid diethylamide (LSD) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT)--and with piperazine moieties--quipazine (Quip) and 6-chloro-2-(1-piperazinyl)pyrazine (6-CPP) were administered to rats....

Ascorbic acid antagonizes the behavioural effects of LSD in cats.

Journal of Pharmacy and Pharmacology December 1, 1985 Michael E. Trulson, Terriann Crisp, Leslie J. Henderson

Pretreatment with ascorbic acid (500 mg kg-1 i.p.) antagonized the behavioural effects of lysergic acid diethylamide (LSD) and apomorphine, but not 5-methoxy-N,N-dimethyltryptamine, in cats. The data support the hypothesis that these behavioural effects in cats are due to drug action at both 5-HT and dopamine receptors, and that the action of LSD at dopamine receptors is modulated by ascorbic...